Deoxycholic Acid

CHEMBL406393 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

392.6 g/mol

LogP

4.9

Phase

4

A naturally occurring bile acid that disrupts and destroys fat cell membranes, used as an injectable treatment to reduce submental fat (the double chin) under the jaw. The destroyed fat cells are permanently eliminated by the body's immune system. Injections can cause swelling, numbness, and bruising, and multiple treatment sessions are typically needed.

Masse moléculaire

392,6000 g/mol

LogP

4,90

TPSA

77,80 Å²

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Rheumatoid Arthritis Gastroesophageal Reflux Disease Non-Alcoholic Fatty Liver Disease Hyperlipidemia Obesity Lymphoma Type 2 Diabetes Breast Cancer Atopic Dermatitis HIV/AIDS Hepatitis C Heart Failure Colorectal Cancer Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C

InChI

InChI=1S/C24H40O4/c1-14(4-9-22(27)28)18-7-8-19-17-6-5-15-12-16(25)10-11-23(15,2)20(17)13-21(26)24(18,19)3/h14-21,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15-,16-,17+,18-,19+,20+,21+,23+,24-/m1/s1

Molecular Formula

C24H40O4

HBD / HBA

3 / 4

Liaisons Rotatives

4

Atomes Lourds

28

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A naturally occurring bile acid that disrupts and destroys fat cell membranes, used as an injectable treatment to reduce submental fat (the double chin) under the jaw. The destroyed fat cells are permanently eliminated by the body's immune system. Injections can cause swelling, numbness, and bruising, and multiple treatment sessions are typically needed.

Yes, Deoxycholic Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL406393. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 222528. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Deoxycholic Acid sur PillFYI

Structure

Données Clés

Formule: C24H40O4
Synonymes: 1

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.